SS-31 (Elamipretide): a mitochondria-targeting peptide
A small peptide studied for its unusual ability to concentrate inside the mitochondria and interact with cardiolipin.
SS-31, also known as elamipretide, is a short synthetic peptide that has drawn attention for a specific reason: it is studied for its ability to concentrate inside the mitochondria, the cell's energy compartments, rather than acting on surface receptors like most peptides.
What makes SS-31 distinctive
Most peptides in this catalogue work by binding receptors on the outside of a cell. SS-31 is different. In the research literature it is described as targeting the inner mitochondrial membrane, where it interacts with a lipid called cardiolipin. Cardiolipin is essential to the machinery that produces cellular energy, which is why a molecule that reaches it is of interest to researchers studying mitochondrial function.
Why researchers study it
Because mitochondrial dysfunction is a theme across many areas of research — from energy metabolism to cellular ageing — a peptide that localises to the mitochondria gives researchers a specific tool to study these systems in laboratory models.
Handling
SS-31 is supplied as a lyophilised powder and reconstituted with bacteriostatic water before use. Its small size makes it straightforward to work with; our reconstitution guide covers the standard method.
Quality you can verify
Every SS-31 batch ships with a certificate of analysis issued within six months of sale, so identity and purity are documented before the vial reaches the bench.
Keep reading
More from the
research bench.
Retatrutide: the triple agonist explained
One molecule, three receptor pathways. Why retatrutide is one of the most closely watched compounds in modern metabolic research.
Tirzepatide: the dual GIP/GLP-1 agonist
How engaging two incretin pathways at once set tirzepatide apart, and what researchers study it for.
NAD+ and mitochondrial research
Why NAD+ sits at the centre of cellular energy research, and what its decline is studied to reveal.
